These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 33862143)

  • 1. Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studies.
    Consonni M; Dalla Bella E; Bersano E; Lauria G
    Neurosci Lett; 2021 May; 754():135898. PubMed ID: 33862143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival.
    Xu Z; Alruwaili ARS; Henderson RD; McCombe PA
    J Neurol Sci; 2017 May; 376():16-23. PubMed ID: 28431606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment across ALS clinical stages in a population-based cohort.
    Chiò A; Moglia C; Canosa A; Manera U; Vasta R; Brunetti M; Barberis M; Corrado L; D'Alfonso S; Bersano E; Sarnelli MF; Solara V; Zucchetti JP; Peotta L; Iazzolino B; Mazzini L; Mora G; Calvo A
    Neurology; 2019 Sep; 93(10):e984-e994. PubMed ID: 31409738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
    Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
    J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and behavioural impairment in amyotrophic lateral sclerosis.
    Pender N; Pinto-Grau M; Hardiman O
    Curr Opin Neurol; 2020 Oct; 33(5):649-654. PubMed ID: 32833751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis.
    Consonni M; Contarino VE; Catricalà E; Dalla Bella E; Pensato V; Gellera C; Lauria G; Cappa SF
    Neuroimage Clin; 2018; 19():675-682. PubMed ID: 30023173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Longitudinal Changes in EEG Measures Reflecting Functional Network Disruption in ALS Cognitive Phenotypes.
    Metzger M; Dukic S; McMackin R; Giglia E; Mitchell M; Bista S; Costello E; Peelo C; Tadjine Y; Sirenko V; McManus L; Buxo T; Fasano A; Chipika R; Pinto-Grau M; Schuster C; Heverin M; Coffey A; Broderick M; Iyer PM; Mohr K; Gavin B; Pender N; Bede P; Muthuraman M; Hardiman O; Nasseroleslami B
    Brain Topogr; 2024 Oct; 38(1):3. PubMed ID: 39367160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis.
    Maranzano A; Poletti B; Solca F; Torre S; Colombo E; Faré M; Ferrucci R; Carelli L; Verde F; Morelli C; Silani V; Ticozzi N
    Eur J Neurol; 2022 May; 29(5):1402-1409. PubMed ID: 34989063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study.
    Bersano E; Sarnelli MF; Solara V; Iazzolino B; Peotta L; De Marchi F; Facchin A; Moglia C; Canosa A; Calvo A; Chiò A; Mazzini L
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):373-379. PubMed ID: 32484726
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and motor-functional correlates of frontotemporal-spectrum disorders in a large cohort of non-demented ALS patients.
    Poletti B; Aiello EN; Consonni M; Iazzolino B; Torre S; Solca F; Faltracco V; Telesca A; Palumbo F; Dalla Bella E; Bersano E; Riva N; Verde F; Messina S; Doretti A; Maranzano A; Morelli C; Calvo A; Silani V; Lauria G; Chiò A; Ticozzi N
    J Neurol; 2024 Oct; 271(10):6944-6955. PubMed ID: 39235524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and behavioural changes in PLS and PMA:challenging the concept of restricted phenotypes.
    de Vries BS; Rustemeijer LMM; Bakker LA; Schröder CD; Veldink JH; van den Berg LH; Nijboer TCW; van Es MA
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):141-147. PubMed ID: 30076267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis.
    Huynh W; Ahmed R; Mahoney CJ; Nguyen C; Tu S; Caga J; Loh P; Lin CS; Kiernan MC
    Expert Rev Neurother; 2020 Mar; 20(3):281-293. PubMed ID: 32031423
    [No Abstract]   [Full Text] [Related]  

  • 13. Inside minds, beneath diseases: social cognition in amyotrophic lateral sclerosis-frontotemporal spectrum disorder.
    Lillo P; Caramelli P; Musa G; Parrao T; Hughes R; Aragon A; Valenzuela D; Cea G; Aranguiz R; Guimarães HC; Rousseff L; Gambogi LB; Mariano LI; Teixeira AL; Slachevsky A; de Souza LC
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1279-1282. PubMed ID: 32962983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods.
    Simon N; Goldstein LH
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):1-11. PubMed ID: 30585510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Story of the ALS-FTD continuum retold: rather two distinct entities.
    Lulé DE; Aho-Özhan HEA; Vázquez C; Weiland U; Weishaupt JH; Otto M; Anderl-Straub S; Semler E; Uttner I; Ludolph AC
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):586-589. PubMed ID: 30257969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis.
    Beeldman E; Govaarts R; de Visser M; Klein Twennaar M; van der Kooi AJ; van den Berg LH; Veldink JH; Pijnenburg YAL; de Haan RJ; Schmand BA; Raaphorst J
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):779-780. PubMed ID: 32404381
    [No Abstract]   [Full Text] [Related]  

  • 17. Cognition and motor phenotypes in ALS: a retrospective study.
    Aiello EN; Pain D; Radici A; Aktipi KM; Sideri R; Appollonio I; Mora G
    Neurol Sci; 2022 Sep; 43(9):5397-5402. PubMed ID: 35608739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the revised classification of cognitive and behavioural impairment in ALS.
    Iazzolino B; Pain D; Peotta L; Calvo A; Moglia C; Canosa A; Manera U; Ilardi A; Bombaci A; Zucchetti JP; Mora G; Chio A
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):734-739. PubMed ID: 30733331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis.
    Iazzolino B; Grassano M; Moglia C; Canosa A; Manera U; Vasta R; Cabras S; Callegaro S; Matteoni E; Di Pede F; Palumbo F; Mora G; Calvo A; Chiò A
    J Neurol; 2024 Feb; 271(2):955-961. PubMed ID: 37880536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological impairment in amyotrophic lateral sclerosis-frontotemporal spectrum disorder.
    Abrahams S
    Nat Rev Neurol; 2023 Nov; 19(11):655-667. PubMed ID: 37828358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.